HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Fructis Products From Mexico, South Korea Aloe Gels On FDA Import Alerts

This article was originally published in The Rose Sheet

Executive Summary

Benton Korea and Ezekiel Cosmetics each shipped 12 products to the US labeled with claims or ingredients, other than aloe, that render them drugs under FDA regulations. Fructis brand hair care products made by two Mexico firms also were detained due to drug claims

You may also be interested in...



Yohimbe Ban Suggested, 'God' Warned: Health And Wellness Industry News

ED-spiked supplement importers identified; FDA and FTC act on GAO outreach suggestion; ephedra-like rulemaking needed for yohimbe – study; and God's book among violative claims by Florida firm.

Aloe Drug Claims Land Indian Firm On FDA Import Alert List

The June 2 update to FDA's list of businesses and their products banned from import also increases the number of Canadian firms identified during 2017 as shipping supplement products that make drug claims or that were made in facilities out of compliance with the agency's good manufacturing practices regulations.

Ultrahuman Expands Wearable Medtech Production Into US After $35M Funding Round

Firm operating in London, India and United Arab Emirates says its “Ultra Factory” will open in Indiana within the next six months with end-to-end production based on its operational facility in India.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121072

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel